Oak Street Health Future Growth
Future criteria checks 2/6
Oak Street Health is forecast to grow earnings and revenue by 53.6% and 23.4% per annum respectively while EPS is expected to grow by 55.2% per annum.
Key information
53.6%
Earnings growth rate
55.2%
EPS growth rate
| Healthcare earnings growth | 27.3% |
| Revenue growth rate | 23.4% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 18 Apr 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 5,215 | -120 | -88 | 117 | 5 |
| 12/31/2024 | 4,117 | -263 | -191 | -84 | 14 |
| 12/31/2023 | 3,053 | -368 | -289 | -227 | 17 |
| 12/31/2022 | 2,161 | -509 | -399 | -309 | N/A |
| 9/30/2022 | 1,977 | -515 | -393 | -285 | N/A |
| 6/30/2022 | 1,820 | -494 | -398 | -295 | N/A |
| 3/31/2022 | 1,650 | -442 | -353 | -260 | N/A |
| 12/31/2021 | 1,430 | -409 | -278 | -197 | N/A |
| 9/30/2021 | 1,285 | -358 | -230 | -181 | N/A |
| 6/30/2021 | 1,114 | -282 | -147 | -116 | N/A |
| 3/31/2021 | 976 | -159 | -94 | -69 | N/A |
| 12/31/2020 | 883 | -120 | -98 | -77 | N/A |
| 9/30/2020 | 808 | -85 | -77 | -57 | N/A |
| 6/30/2020 | 729 | -93 | -103 | -79 | N/A |
| 3/31/2020 | 641 | -145 | -88 | -63 | N/A |
| 12/31/2019 | 557 | -137 | -83 | -55 | N/A |
| 9/30/2019 | 470 | -119 | -65 | -35 | N/A |
| 12/31/2018 | 318 | -119 | -101 | -75 | N/A |
| 12/31/2017 | 185 | -55 | -48 | -35 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OSH * is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: OSH * is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: OSH * is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: OSH *'s revenue (23.4% per year) is forecast to grow faster than the MX market (6.2% per year).
High Growth Revenue: OSH *'s revenue (23.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OSH *'s Return on Equity is forecast to be high in 3 years time